A detailed history of Jpmorgan Chase & CO transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 342,667 shares of MGTX stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
342,667
Previous 338,481 1.24%
Holding current value
$2.22 Million
Previous $1.43 Million 0.21%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$3.88 - $5.23 $16,241 - $21,892
4,186 Added 1.24%
342,667 $1.43 Million
Q2 2024

Aug 12, 2024

SELL
$4.21 - $5.81 $84,065 - $116,014
-19,968 Reduced 5.57%
338,481 $1.43 Million
Q1 2024

May 10, 2024

SELL
$5.78 - $7.33 $150,251 - $190,543
-25,995 Reduced 6.76%
358,449 $2.18 Million
Q4 2023

Feb 12, 2024

BUY
$3.6 - $7.15 $21,330 - $42,363
5,925 Added 1.57%
384,444 $2.7 Million
Q3 2023

Nov 14, 2023

BUY
$4.79 - $7.19 $1.45 Million - $2.18 Million
302,650 Added 398.91%
378,519 $1.86 Million
Q2 2023

Aug 11, 2023

SELL
$5.19 - $8.07 $902,032 - $1.4 Million
-173,802 Reduced 69.61%
75,869 $509,000
Q1 2023

May 18, 2023

BUY
$5.04 - $8.6 $126,559 - $215,954
25,111 Added 11.18%
249,671 $1.29 Million
Q1 2023

May 11, 2023

SELL
$5.04 - $8.6 $95,502 - $162,961
-18,949 Reduced 7.78%
224,560 $1.16 Million
Q4 2022

Feb 13, 2023

SELL
$5.8 - $8.98 $25,868 - $40,050
-4,460 Reduced 1.8%
243,509 $1.59 Million
Q3 2022

Nov 14, 2022

SELL
$7.55 - $11.25 $39,554 - $58,938
-5,239 Reduced 2.07%
247,969 $2.09 Million
Q2 2022

Aug 11, 2022

BUY
$6.8 - $14.23 $465,609 - $974,356
68,472 Added 37.06%
253,208 $1.92 Million
Q1 2022

May 11, 2022

SELL
$13.42 - $23.38 $102,864 - $179,207
-7,665 Reduced 3.98%
184,736 $2.56 Million
Q4 2021

Feb 10, 2022

SELL
$12.78 - $23.74 $708,484 - $1.32 Million
-55,437 Reduced 22.37%
192,401 $4.57 Million
Q3 2021

Nov 12, 2021

BUY
$11.73 - $16.08 $2.91 Million - $3.99 Million
247,838 New
247,838 $3.27 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.